Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study

Abstract

Swedish Cancer Society, Confederation of Regional Cancer Centres, and Swedish governmental funding for clinical research.